News & Updates
Filter by Specialty:
Pseudopyloric metaplasia does not predict development of gastric cancer
Neither gastric cancer nor gastric dysplasia is seen in patients with corpus atrophic gastritis (CAG) characterized at baseline with corpus pseudopyloric metaplasia (PPM) without corpus intestinal metaplasia (IM) because such lesions are consistently associated with corpus IM, reports a study.
Pseudopyloric metaplasia does not predict development of gastric cancer
10 Oct 2021Antimigraine drugs may complicate pregnancy
The antimigraine medications dihydroergotamine (DHE) and triptan seem to aggravate the risk of adverse pregnancy outcomes such as premature birth and spontaneous abortion (SA), a recent study has found.
Antimigraine drugs may complicate pregnancy
10 Oct 2021ACE inhibitors, ARBs put brakes on emphysema progression, lung function decline in COPD
Angiotensin converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) appear to be beneficial to chronic obstructive pulmonary disease (COPD) patients, with a recent study suggesting that the use of such drugs may slow down progression of emphysema and lung function decline.
ACE inhibitors, ARBs put brakes on emphysema progression, lung function decline in COPD
10 Oct 2021Targeted therapy superior to chemotherapy, best supportive care at improving survival in NSCLC
Survival benefit in patients with de novo stage IV nonsmall-cell lung cancer (NSCLC) depends on the type of treatment received, with significantly better median overall survival (OS) seen with the use of small-molecule targeted therapy against epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements than with best supportive care, reports a study.